eli lilly glp 1 drug to seek approval of new GLP-1 weight-loss this year The Medicine Maker | Insights

eli lilly glp 1 drug

eli lilly glp 1 drug to seek approval of new GLP-1 weight-loss this year The Medicine Maker | Insights

Name: eli lilly glp 1 drug to seek approval of new GLP-1 weight-loss this year The Medicine Maker | Insights
Brand: recreatech.nl
SKU: 1202197852
Price: 23.03 USD
Availability: InStock
Rating: 4.3303 (24 reviews)

SKU: 1202197852

4.3

EUR23.03 EUR45.03

Pay in 4 interest-free payments of $5.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Dirnhofer S,Skoda RC

LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al